How Quickly Do Physicians Adopt New Drugs? The Case of Second-Generation Antipsychotics
Supplemental Material
324_ds001.pdf (145 KB)
The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.
Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.
×324_ds001.pdf (145 KB)
This work was supported by a grant from the National Institute of Mental Health (R01 MH093359), by a Robert Wood Johnson Foundation Investigator Award in Health Policy Research to Dr. Huskamp, and by grants to Dr. Donohue from the Agency for Healthcare Research and Quality (R01HS017695) and the National Institute of Mental Health (NIMH) (R34 MH082682 and P30 MH090333), to Dr. Horvitz-Lennon from NIMH (R01 MH087488), and to Dr. Berndt from the National Science Foundation (0915674). The study is based in part on data obtained under license from IMS Health, Inc. (Xponent, 1996–2008). The statements, findings, conclusions, views, and opinions contained and expressed herein are not necessarily those of IMS Health Inc. or any of its affiliated or subsidiary entities.
Dr. Donohue consulted for the National Railways Labor Conference, which was considering changes to its health benefits for railway workers, in 2011. The other authors report no competing interests.